Abstract
It is a great pleasure and a privilege to welcome you on behalf of the Swiss regulatory agency, the Interkantonale Kontrollstelle für Heilmittel (IKS). The focus of the RAD-AR initiative, namely, the risk/benefit assessment of drugs, has always been the most important and the most demanding task of drug regulatory agencies, not only in Switzerland but in all countries. I am pleased that during the last 2 years our office has undertaken several important steps to improve drug safety.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Pfanner, J. (1991). Intercantonal Office for the Control of Medicines. In: Dinkel, R., Horisberger, B., Tolo, K.W. (eds) Improving Drug Safety — A Joint Responsibility. Health Systems Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61250-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-61250-3_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64762-8
Online ISBN: 978-3-642-61250-3
eBook Packages: Springer Book Archive